DreamTeamDownloads1, FTP Help, Movies, Bollywood, Applications, etc. & Mature Sex Forum, Rapidshare, Filefactory, Freakshare, Rapidgator, Turbobit, & More MULTI Filehosts

DreamTeamDownloads1, FTP Help, Movies, Bollywood, Applications, etc. & Mature Sex Forum, Rapidshare, Filefactory, Freakshare, Rapidgator, Turbobit, & More MULTI Filehosts (http://www.dreamteamdownloads1.com/index.php)
-   Africa/Asia/Australasia/UK/Europe/Americas (http://www.dreamteamdownloads1.com/forumdisplay.php?f=287)
-   -   World Anger >US Rich Man Stops POOR AIDS/Infection Sufferers Buying MEDs (http://www.dreamteamdownloads1.com/showthread.php?t=789293)

Ladybbird 22-09-15 11:45

World Anger >US Rich Man Stops POOR AIDS/Infection Sufferers Buying MEDs
 
Global Outrage and Disgust as GAY Ex-Hedge Funder, 32, Buys Rights to AIDS/Infection Drugs >>>

AND Raises Price 5500% From $13.50 to $750 PER PILL!!!

  • Martin Shkreli, 32, founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim in August for $55million
  • He raised the price of the drug form $13.50 per tablet to $750 per tablet

  • Shkreli has backed the decision, saying that his company 'needed to turn a profit on the drug'
  • Daraprim treats toxoplasmois, an opportunistic parasitic infection that can cause serious and life-threatening problems
  • Hillary Clinton weighed in on the issue, calling the price hike 'outrageous'
  • Shkreli called the editor of Fierce Biotech 'a moron' after he questioned the CEO's reasoning behind increasing the price of Daraprim

By Kelly Mclaughlin, Daily Mail UK, 22 September 2015




http://i.dailymail.co.uk/i/pix/2015/...59_964x400.jpg

Martin Shkreli, 32, founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim which is used for treating life-threatening parasitic infections - for $55million. He raised the price of the drug form $13.50 per tablet to $750 per tablet.


Since the announcement, people across social media have criticized the price increase, but Shkreli has backed the decision, saying that his company 'need to turn a profit on the drug'.


'This isn't the greedy drug company trying to gouge patients, it is us trying to stay in business,' Shkreli said..


He added that many patients use the drug for less than a year and that the price is on par with drugs similar that are used to treat rare diseases.

END



All times are GMT. The time now is 22:49.

Powered by vBulletin® Version 3.8.11
Copyright ©2000 - 2024, vBulletin Solutions Inc.
SEO by vBSEO 3.5.2